Pneumococcal vaccine (Antigenics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePneumococcal vaccine (Antigenics)

Drug Alias NameQuilimmune-P

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPneumococcal Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAgenus Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAgenus Inc

Active IndicationsN/A

Inactive IndicationsPneumococcal Infections

ATC CodeN/A